Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionTompkins Financial Corp
Latest Disclosed Ownership831 shares
Latest Disclosed Value $ 126,935
Tompkins Financial Corp reports 48.39% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 9, 2026 - Tompkins Financial Corp filed a 13F-HR form disclosing ownership of 831 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $106,784 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 560 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 48.39% during the quarter. The current value of the position is $100,551 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 831 271 48.39 127 63.64 0.0089
2026-01-08 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 560 0 0.00 77 8.45 0.0060
2025-10-08 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 560 -1,250 -69.06 72 -67.58 0.0060
2025-07-10 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,810 -1,100 -37.80 219 -32.41 0.0201
2025-04-07 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,910 0 0.00 324 14.49 0.0310
2025-01-15 2024-12-31 13F Novartis SPONSORED ADR 66987V109 2,910 0 0.00 283 -15.27 0.0263
2024-11-01 2024-09-30 13F Novartis SPONSORED ADR 66987V109 2,910 0 0.00 335 8.09 0.0321
2024-07-17 2024-06-30 13F Novartis SPONSORED ADR 66987V109 2,910 -63 -2.12 310 7.67 0.0324
2024-04-08 2024-03-31 13F Novartis SPONSORED ADR 66987V109 2,973 663 28.70 288 23.18 0.0325
2024-01-08 2023-12-31 13F Novartis SPONSORED ADR 66987V109 2,310 0 0.00 233 -0.85 0.0283
2023-11-21 2023-09-30 13F Novartis SPONSORED ADR 66987V109 2,310 0 0.00 235 0.86 0.0370
2023-07-12 2023-06-30 13F Novartis SPONSORED ADR 66987V109 2,310 -334 -12.63 233 -4.12 0.0365
2023-04-20 2023-03-31 13F Novartis SPONSORED ADR 66987V109 2,644 -50 -1.86 243 0.0396
2023-01-06 2022-12-31 13F Novartis SPONSORED ADR 66987V109 2,694 0 0.00 0 -100.00 0.0386
2022-10-13 2022-09-30 13F Novartis SPONSORED ADR 66987V109 2,694 0 0.00 205 -10.09 0.0346
2022-07-14 2022-06-30 13F Novartis SPONSORED ADR 66987V109 2,694 -465 -14.72 228 -17.99 0.0366
2022-05-12 2022-03-31 13F Novartis SPONSORED ADR 66987V109 3,159 560 21.55 278 22.47 0.0392
2022-01-24 2021-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,599 0 0.00 227 6.57 0.0403
2021-10-22 2021-09-30 13F NOVARTIS INTERNATIONAL 66987V109 2,599 -586 -18.40 213 -21.69 0.0389
2021-06-09 2021-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 3,185 -139 -4.18 272 -13.38 0.0460
2021-02-12 2020-12-31 13F/A-1 NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 3,324 39 1.19 314 9.79 0.0565
2021-02-05 2020-12-31 13F NOVARTIS A G SPONSORED ADR NON-US EQUITY (DEVELOPED) 66987V109 36,779 33,494 3,033 127,672.3640
2020-10-23 2020-09-30 13F NOVARTIS A G INTERNATIONAL 66987V109 3,285 0 0.00 286 -0.35 0.0550
2020-07-29 2020-06-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 3,285 0 0.00 287 5.90 0.0603
2020-04-22 2020-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 3,285 -25 -0.76 271 -13.42 0.0625
2020-01-22 2019-12-31 13F/A-1 NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 3,310 1,100 49.77 313 63.02 0.0574
2020-01-15 2019-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,210 0 192 29,161.6039
2019-10-17 2019-09-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,210 0 0.00 192 -4.95 0.0390
2019-07-17 2019-06-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,210 -25 -1.12 202 -6.05 0.0406
2019-04-30 2019-03-31 13F/A-1 NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,235 -450 -16.76 215 -6.52 0.0408
2019-04-17 2019-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,685 0 231
2019-01-22 2018-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,685 0 0.00 230 -0.43 0.0508
2018-10-18 2018-09-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,685 0 0.00 231 13.79 0.0474
2018-07-18 2018-06-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,685 575 27.25 203 18.71 0.0437
2018-04-26 2018-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,110 1,835 667.27 171 643.48 0.0383
2018-01-24 2017-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 275 -603 -68.68 23 -69.33 0.0053
2017-10-17 2017-09-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 878 0 0.00 75 2.74 0.0178
2017-07-11 2017-06-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 878 0 0.00 73 12.31 0.0184
2017-04-17 2017-03-31 13F/A-1 NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 878 0 0.00 65 1.56 0.0165
2017-04-17 2017-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 849 61
2017-01-10 2016-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 878 0 0.00 64 -7.25 0.0168
2016-10-13 2016-09-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 878 29 3.42 69 -1.43 0.0198
2016-07-13 2016-06-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 849 0 0.00 70 14.75 0.0207
2016-04-20 2016-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 849 -225 -20.95 61 -34.41 0.0193
2016-01-19 2015-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,074 0 0.00 93 -6.06 0.0296
2015-10-16 2015-09-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,074 -2 -0.19 99 -6.60 0.0320
2015-07-14 2015-06-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,076 0 0.00 106 0.00 0.0288
2015-04-21 2015-03-31 13F/A-1 NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,076 -995 -48.04 106 -44.79 0.0265
2015-04-14 2015-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,076 106
2015-01-15 2014-12-31 13F/A-1 NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,071 0 0.00 192 -1.54 0.0479
2015-01-13 2014-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,295 92
2014-10-10 2014-09-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,071 35 1.72 195 5.98 0.0511
2014-07-11 2014-06-30 13F NOVARTIS A G INTERNATIONAL 66987V109 2,036 0 0.00 184 5.75 0.0455
2014-04-10 2014-03-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,036 0 0.00 174 6.10 0.0440
2014-01-08 2013-12-31 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 2,036 741 57.22 164 65.66 0.0425
2013-10-11 2013-09-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,295 0 0.00 99 7.61 0.0277
2013-07-19 2013-06-30 13F NOVARTIS AG SPNSRD ADR INTERNATIONAL 66987V109 1,295 1,295 92 0.0278
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.